Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. anaprint

ANAPRINT SIGNED

Additive Printing for Cell-Based Analysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ANAPRINT project word cloud

Explore the words cloud of the ANAPRINT project. It provides you a very rough idea of what is the project "ANAPRINT" about.

goals    mature    evidenced    scalable    compromise    manufacture    scoped    models    locations    customer    advantage    lucrative    assembly    national    core    resident    competitive    advantages    discovery    confirmed    supply    biological    marketplace    printing    food    strategic    natural    unlike    manufactured    presently    drug    3d    combines    onto    positive    analytical    sme    profitable    delivering    assemble    cell    commercial    instrument    measurable    additively    mapped    automated    uk    achievement    industrial    friendliness    plan    environment    disruptive    biosafety    tool    infrastructure    frozen    create    trl7    services    preclinical    ready    convenience    exceptional    nanosafety    output    founded    exists    proprietary    business    underpinning    exemplifying    hepatotoxicity    market    medical    printed    ancillary    corporate    additive    customers    solution    assay    assembled    predictive    outcome    manufacturing    industry    cells    cross    demonstrable   

Project "ANAPRINT" data sheet

The following table provides information about the project.

Coordinator		 AvantiCell Science Ltd 

Organization address
address: GIBBSYARD BUILDING
city: AYR
postcode: KA6 5HW
website: www.avanticell.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website http://www.avanticell.com/technologies/projects/anaprint
 Total cost 1˙803˙657 €
 EC max contribution 1˙262˙560 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-2-2015
 Funding Scheme SME-2
 Starting year 2015
 Duration (year-month-day) from 2015-11-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AvantiCell Science Ltd UK (AYR) coordinator 1˙262˙560.00

Map

 Project objective

The Project shall develop a unique manufacturing solution for the automated production of complex cell models widely used by industry to test biological activity and biosafety. No means of scalable manufacture presently exists. The technical solution is to assemble cell models by additive manufacturing; to control the resident cells’ locations within these 3D models; to supply the models to customers as pre-assembled, frozen products. The result shall be an analytical tool which, unlike current practice, does not compromise analytical output for convenience, but combines high predictive value and low cost with exceptional user-friendliness. The solution is unique, proprietary and highly positive-disruptive in its industrial sector. Its achievement will be measurable in this Project as an exemplifying, printed hepatotoxicity assay with wide application in drug discovery and biosafety testing. An SME Instrument Phase 1 Project advanced the core printing technology delivering this solution to TRL7, and developed a business plan for its exploitation. That business plan confirmed the wide, cross-industry application of cell-based analysis, from preclinical drug discovery through natural products/food to medical devices and nanosafety, and mapped the advantages of additively-manufactured products onto demonstrable industry trends and customer needs. The business plan and its underpinning technology are founded in the applicant’s long-term strategic goals, evidenced by profitable business in the target market from proprietary cell-based services, and by ancillary technology developments, also to TRL7 and supported by UK national funding, which create unique competitive advantage. The outcome of this Phase 2 Project will be a mature cell-based manufacturing technology, its demonstrable application in a commercial environment, and the assembly of a corporate infrastructure ready to take the Project’s manufacturing solution into a well-scoped and lucrative marketplace.

 Deliverables

List of deliverables.
Documents Defining Technical Performance Documents, reports 2019-04-09 14:22:00

Take a look to the deliverables list in detail:  detailed list of ANAPRINT deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ANAPRINT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ANAPRINT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More